Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
2.260
-0.200 (-8.13%)
At close: May 22, 2026, 4:00 PM EDT
2.230
-0.030 (-1.33%)
After-hours: May 22, 2026, 7:56 PM EDT

Clearmind Medicine Income Statement

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Selling, General & Admin
5.63.614.364.763.172.22
Research & Development
2.242.061.381.543.080.47
Total Operating Expenses
7.835.675.746.36.252.69
Operating Income
-7.83-5.67-5.74-6.3-6.25-2.69
Interest Income
0.160.130.270.07--
Other Non-Operating Income (Expense)
1.271.750.6-2.39-0.61-0.02
Total Non-Operating Income (Expense)
1.441.880.87-2.32-0.61-0.02
Pretax Income
-6.6-3.79-4.88-8.6-6.87-2.73
Provision for Income Taxes
0.040.070.380.020.03-
Net Income
-5.95-3.86-5.25-8.62-6.89-2.73
Net Income to Common
-5.95-3.86-5.25-8.62-6.89-2.73
Shares Outstanding (Basic)
000000
Shares Outstanding (Diluted)
000000
Shares Change (YoY)
305.23%63.98%1431.08%367.24%40.19%70.50%
EPS (Basic)
-244.60-303.50-678.00-17030.40-63644.00-35264.00
EPS (Diluted)
-244.60-303.50-678.00-17030.40-63644.00-35264.00
Shares Outstanding
0.150.020.01000
Free Cash Flow
-5.55-4.73-4.86-6.3-3.73-2.09
Free Cash Flow Per Share
-142.56-372.52-626.90-12448.60-34430.00-27097.90
EBITDA
-7.78-5.62-5.69-6.25-6.17-2.69
EBIT
-7.83-5.67-5.74-6.3-6.25-2.69
Effective Tax Rate
-0.53%-1.86%-7.75%-0.20%-0.43%0.00%
Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q